Huadong Medicine
Chinese pharmaceutical company
From Wikipedia, the free encyclopedia
HD Medicine, or Huadong Medicine Co., Ltd., is a Hangzhou-based pharmaceutical company registered on the Shenzhen Stock Exchange since January 27, 2000. It has a listed share capital of 380,000,000 renminbi and a market capitalization of 126,323,040 renminbi as of July 2005[update]. It is the largest pharmaceutical company in Zhejiang and the leading immunosuppressant manufacturer in China.[1]
| SZSE: 000963 | |
| Industry | Pharmaceuticals |
| Founded | 1993 |
| Headquarters | Hangzhou, China |
| Website | www |
In June 2025, the company received approval to commence clinical trials for Roflumilast Foam, targeting dermatological conditions. [2]
